Ultragenyx Pharmaceutical
RARE
#3399
Rank
A$5.04 B
Marketcap
$53.77
Share price
-6.92%
Change (1 day)
-25.21%
Change (1 year)

EPS for Ultragenyx Pharmaceutical (RARE)

EPS in 2023 (TTM): -$15.42

According to Ultragenyx Pharmaceutical's latest financial reports the company's current EPS (TTM) is -$16.34. In 2022 the company made an earnings per share (EPS) of -$16.13 a decrease over its 2021 EPS that were of -$10.71.

EPS history for Ultragenyx Pharmaceutical from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$15.42-4.43%
2022-$16.1350.67%
2021-$10.71113.69%
2020-$5.01-55.9%
2019-$11.3682.56%
2018-$6.22-45.15%
2017-$11.3414.68%
2016-$9.8957.36%
2015-$6.2969.83%
2014-$3.7015.22%
2013-$3.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.24-107.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.02-93.75%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.50-72.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.08-93.36%๐Ÿ‡บ๐Ÿ‡ธ USA